These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18037316)

  • 21. Growth hormone isoform responses to GABA ingestion at rest and after exercise.
    Powers ME; Yarrow JF; McCoy SC; Borst SE
    Med Sci Sports Exerc; 2008 Jan; 40(1):104-10. PubMed ID: 18091016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins.
    White T; Ozel B; Jain JK; Stanczyk FZ
    Contraception; 2006 Oct; 74(4):293-6. PubMed ID: 16982228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of resistance exercise on lipolysis during subsequent submaximal exercise.
    Goto K; Ishii N; Sugihara S; Yoshioka T; Takamatsu K
    Med Sci Sports Exerc; 2007 Feb; 39(2):308-15. PubMed ID: 17277595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single circuit-resistance exercise has no effect on plasma obestatin levels in female college students.
    Ghanbari-Niaki A; Saghebjoo M; Rahbarizadeh F; Hedayati M; Rajabi H
    Peptides; 2008 Mar; 29(3):487-90. PubMed ID: 18308154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-affinity growth hormone binding protein and acute heavy resistance exercise.
    Rubin MR; Kraemer WJ; Maresh CM; Volek JS; Ratamess NA; Vanheest JL; Silvestre R; French DN; Sharman MJ; Judelson DA; Gómez AL; Vescovi JD; Hymer WC
    Med Sci Sports Exerc; 2005 Mar; 37(3):395-403. PubMed ID: 15741837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of elevated circulating hormones on resistance exercise-induced Akt signaling.
    Spiering BA; Kraemer WJ; Anderson JM; Armstrong LE; Nindl BC; Volek JS; Judelson DA; Joseph M; Vingren JL; Hatfield DL; Fragala MS; Ho JY; Maresh CM
    Med Sci Sports Exerc; 2008 Jun; 40(6):1039-48. PubMed ID: 18461003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
    O'Connell KJ; Osborne LM; Westhoff C
    Contraception; 2005 Nov; 72(5):323-7. PubMed ID: 16246655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid reesterification but not oxidation is increased by oral contraceptive use in women.
    Jacobs KA; Casazza GA; Suh SH; Horning MA; Brooks GA
    J Appl Physiol (1985); 2005 May; 98(5):1720-31. PubMed ID: 15618322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of gender, menstrual phase, and oral contraceptive use on immunological changes in response to prolonged cycling.
    Timmons BW; Hamadeh MJ; Devries MC; Tarnopolsky MA
    J Appl Physiol (1985); 2005 Sep; 99(3):979-85. PubMed ID: 15879167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
    J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-transfer effects of resistance training with blood flow restriction.
    Madarame H; Neya M; Ochi E; Nakazato K; Sato Y; Ishii N
    Med Sci Sports Exerc; 2008 Feb; 40(2):258-63. PubMed ID: 18202577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bone sparing effect of oral contraceptive use in non-smoking women.
    Kitai E; Blum M; Kaplan B
    Clin Exp Obstet Gynecol; 1992; 19(1):30-3. PubMed ID: 1606695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP; Mathias A
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
    Peters C; Burrows M
    Contraception; 2006 Dec; 74(6):487-91. PubMed ID: 17157107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
    Burkman RT; Fisher AC; LaGuardia KD
    J Reprod Med; 2007 Nov; 52(11):1030-4. PubMed ID: 18161401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone, arginine and exercise.
    Kanaley JA
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):50-4. PubMed ID: 18090659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of growth hormone aggregates to different intermittent exercise intensities.
    Rubin MR; Kraemer WJ; Kraemer RR; Durand RJ; Acevedo EO; Johnson LG; Castracane VD; Scheett TP; French DN; Volek JS
    Eur J Appl Physiol; 2003 Apr; 89(2):166-70. PubMed ID: 12665980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of increased dietary calcium on hemorheological, lipid and lipid peroxidation in oral contraceptive-treated female rats.
    Olatunji LA; Soladoye AO; Oyeyipo PI
    Clin Hemorheol Microcirc; 2008; 38(2):135-42. PubMed ID: 18198414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of moderate ethanol drinking on the GH and cortisol responses to physical exercise.
    Coiro V; Casti A; Saccani Jotti G; Rubino P; Manfredi G; Maffei ML; Di Gennaro C; Melani A; Chiodera P
    Neuro Endocrinol Lett; 2007 Apr; 28(2):145-8. PubMed ID: 17435673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.